(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 73.76%-20.48K | 46.22%-30.41K | 80.12%-107.37K | 124.96%51.5K | 75.87%-24.28K | 27.68%-78.04K | 54.83%-56.54K | 29.09%-540.03K | -273.42%-206.33K | 74.71%-100.64K |
Net income from continuing operations | 85.17%-7.81K | -50.24%-88.54K | 88.48%-277.82K | 55.92%-107.44K | 34.55%-58.79K | 97.18%-52.66K | 72.06%-58.93K | 14.39%-2.41M | 59.45%-243.74K | 87.29%-89.83K |
Asset impairment expenditure | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 292.34%1.77M | -47.91%69.53K | --0 |
Remuneration paid in stock | --0 | --289 | -89.29%27.62K | -85.14%24.7K | -56.60%1.63K | -82.04%1.28K | --0 | -50.98%257.91K | -60.33%166.2K | -96.49%3.77K |
Change In working capital | 52.50%-12.67K | 2,318.06%57.84K | 189.44%142.83K | 167.69%134.23K | 325.67%32.88K | -155.31%-26.67K | -51.80%2.39K | -59.80%-159.7K | -313.99%-198.32K | 87.51%-14.57K |
-Change in receivables | 306.71%7.36K | -179.80%-6.68K | 610.73%71.55K | 1,350.71%79.81K | 75.31%-2.31K | 66.72%-3.56K | -119.21%-2.39K | 75.90%-14.01K | 34.44%-6.38K | 36.17%-9.34K |
-Change in prepaid assets | 7.48%-11.3K | -68.60%2.3K | -70.93%2.92K | -50.72%3.61K | -42.55%4.21K | -626.96%-12.21K | 351.62%7.32K | 174.60%10.05K | -3.85%7.32K | 180.65%7.32K |
-Change in payables and accrued expense | 19.85%-8.73K | 2,545.64%62.22K | 143.89%68.36K | 125.50%50.82K | 346.93%30.98K | -117.97%-10.89K | 44.03%-2.54K | -449.69%-155.74K | -310.19%-199.26K | 86.50%-12.55K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 73.76%-20.48K | 46.22%-30.41K | 80.12%-107.37K | 124.96%51.5K | 75.87%-24.28K | 27.68%-78.04K | 54.83%-56.54K | 29.09%-540.03K | -273.47%-206.33K | 74.71%-100.64K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -3,504.28%-379.35K | 0 | 100.56%3.91K | -87.81%10.1K | 96.78%-19.11K | 91.33%-10.53K | 139.01%23.44K | 68.01%-691.3K | 108.74%82.82K | -878.19%-592.7K |
Net PPE purchase and sale | ---- | ---- | 97.17%-19.75K | -83.36%10.1K | 96.78%-19.11K | ---- | ---- | 65.47%-698.45K | 106.96%60.67K | -45,309.99%-592.7K |
Net other investing changes | ---- | ---- | 231.16%23.66K | --0 | --0 | --218 | --23.44K | 111.54%7.14K | --22.15K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -3,504.28%-379.35K | --0 | 100.56%3.91K | -87.81%10.1K | 96.78%-19.11K | 91.33%-10.53K | 139.01%23.44K | 68.01%-691.3K | 108.74%82.82K | -878.19%-592.7K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Cash from discontinued financing activities | ||||||||||
Net cash flow | ||||||||||
Beginning cash position | -15.97%530.13K | -15.58%560.54K | -64.97%664K | -36.64%498.94K | -63.38%542.33K | -63.11%630.9K | -64.97%664K | 39.65%1.9M | -71.41%787.51K | -54.02%1.48M |
Current changes in cash | -351.44%-399.83K | 8.14%-30.41K | 91.60%-103.46K | 149.87%61.59K | 93.74%-43.39K | 61.37%-88.57K | 82.13%-33.1K | -328.81%-1.23M | 85.63%-123.51K | -48.79%-693.34K |
End cash Position | -75.97%130.3K | -15.97%530.13K | -15.58%560.54K | -15.58%560.54K | -36.64%498.94K | -63.38%542.33K | -63.11%630.9K | -64.97%664K | -64.97%664K | -71.41%787.51K |
Free cash from | -350.33%-399.83K | 46.22%-30.41K | 89.74%-127.12K | 142.29%61.59K | 93.74%-43.39K | 58.56%-88.79K | 69.48%-56.54K | 55.52%-1.24M | 80.65%-145.66K | -74.85%-693.34K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data